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Abstract: We investigated whether rCBF values obtained with the SPECT technique are
different in schizophrenics with predominantly positive or negative symptoms and assessed
the biological underpinnings of psychotic phenomena, which has been done repeatedly in
the past, with somewhat varied results.
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Twenty-nine schizophrenic patients were
examined to investigate the relationship
between regional cerebral blood flow (rCBF)
and psychopathology according to SANS,
SAPS and BPRS scores. Using the Tc-99m
HMPAO SPECT method at rest, rCBF was
assessed in 15 patients with predominantly
positive (group I) and 14 with predominantly
negative (group II) symptoms. Ten agematched normal healthy volunteers comprised
the control group.
We found that the rCBF of group II was
prominently decreased in the temporal region

Introduction
Recent studies of the etiology and pathogenesis of
schizophrenia are characterized by an emphasis on the
distinction
between
positive
and
negative
symptomatology. Some SPECT/PET studies have
reported diffuse hyperactivation (1), normal cerebral
tracer uptake (2) in patients with predominantly positive
symptoms, and prefrontal hypometabolism (3-5) and
increased rCBF in the left thalamus and right basal ganglia
(5) in schizophrenia with predominantly negative
symptoms.
Studies related to measurement of rCBF in
schizophrenic patients might reveal important data
enlightening the etiology of this disease. To date,
although a large amount of work has been done on
symptoms generally, limited studies have been done on
the measurement of rCBF, which may be helpful for
etiologic subclassification of schizophrenia.

compared to that of group I. Basal ganglia
rCBF demonstrated a hyperperfusion pattern
in medicated vs non-medicated patients
(p<0.05). Negative symptom scores showed a
positive correlation, particularly with left
parietal blood flows, and a negative
correlation with temporal region blood flows;
positive symptom scores showed correlations
positively with temporal region blood flow
and negatively with left parieto-temporal
blood flows.
It is suggested that positive/negative
symptoms might reflect a dysfunction of
fronto-parieto-temporal
heteromodal
association cortices.

Key Words: schizophrenia, negative/positive
symptoms, SPECT.

We investigated whether rCBF values are different in
schizophrenics with predominantly positive or negative
symptoms who had been shown to have differences in
terms of clinical, biochemical and structural views in
previous studies.

Materials and Methods
Subjects
Twenty-nine schizophrenic patients (21 male and 8
female) were included in the study. The diagnosis of
schizophrenia was made according to DSM-IV (6) Ten
aged-matched healthy volunteers (7 male, 3 female)
comprised the control group. Mean ages of female and
male patients were 32.8 (16-59) and 33.7 (16-52)
years, respectively. Mean period of disease was 6.5 in
female and 10.8 years in male patients. Seventeen
patients were not taking any neuroleptic drug at least 6
weeks before the assessment time. All the subjects were
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right-handed and gave their informed consent to
participate in the study.
Psychopathology
For the evaluation of symptoms of patients, the Scale
for the Assessment of Negative Symptoms (SANS) (7),
the Scale for the Assessment of Positive Symptoms
(SAPS) (8) and the Brief Psychiatric Rating Scale (BPRS)
(9) were utilized. These scales’ reliability and validity had
been previously tested in Turkey (10,11). Assessment of
global severity was made by the 18–item BPRS total
score. Positive symptoms were assessed by the sum of
the following four BPRS items: conceptual
disorganization, suspiciousness, hallucinatory behavior
and unusual thought content. In this scale “diminished
emotional range”, “motor retardation” and “blunted
affect” sub-items were assessed as negative symptoms
(12).
Imaging Protocol
Regional cerebral blood flow at rest was evaluated
with the SPECT technique. 740 MBq Tc-99m-HMPAO
was injected intravenously to the patients and controls.
Acquisition started 15-20 min after injection. The SPECT
study was performed under less lighted and quiet
conditions when patients were in a resting position and
their eyes were closed. The SPECT studies were
performed using a gamma camera equipped with a low
energy, general-purpose parallel-hole collimator, and
interfaced with a computer. (General Electric-Starcam
4000-X C/T). SPECT data were collected from 64
projections with a 64x64 matrix and 1.33 zoom in
circular orbit, and an energy window of 20% was
selected. Projections were pre-processed using a
Hamming Filter from available software, and transversal,
frontal, saggital and oblique sections parallel to the
orbitomeatal plane were reconstructed by filtered
backprojection algorithms. Slice thickness was 1 pixel
width. For quantitative evaluation, 16 regions of interest
(ROI) on the 3 consecutive orbito meatal line slices (OML)
were drawn. The ROIs drawn on the first OML slice were
compatible with prefrontal, parietal and parieto-occipital
regions. The second OML slice included the ROIs of the
frontal, parieto-temporal and occipital lobes and basal
ganglia. There were only 2 ROIs on the third OML slices
representative of bilateral temporal lobes.
The ratios of the mean counts of these 16 ROIs to the
mean counts of the whole brain were obtained. These
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ratios were expressed as ROI/total brain indices. The
quantitative indices of the patients with negative and
positive symptoms, medicated patients, drug-naive
patients and controls were compared. The assessment of
SPECT images was performed by two nuclear medicine
physicians who were blind to the subjects’ clinical status.
Statistical Analysis
The Mann-Whitney U test was used to evaluate
differences between schizophrenics with positive and
negative symptoms and controls in terms of mean rCBF
values. We used Spearman’s Rank test for correlation
analysis. A stepwise multiple regression analysis was
performed to control for the possible confounding
influence of gender, age, and treatment of each of the
patients. Statistical analyses were performed using the
SPSS (13).

Results
There were 15 patients whose positive symptoms
were dominant (group I: 10 males and 5 females) and 14
whose negative symptoms were dominant (group II: 11
males and 3 females). The right temporal (p<0.01) and
left temporal rCBF (p<0.05) results of group I were
significantly higher than those of group II. Mean rCBF
values of various regions of the brain are shown in the
Figure.
By stepwise regression analysis, for each patient the
partial correlation factor for treatment, age, gender was
very low (<0.001 to 0.1) and was not significant.
Significant correlations between SANS, SAPS and
BPRS scores and rCBF measurements are given in Table.
While group I had decreased values compared to both
group II and the controls, decreases in the right temporal
and left temporal blood flow rates were at a statistically
significant level (p>0.05). A comparison between the
rCBF values of the patient and control groups indicated
that the two groups differed significantly from each
other, with the patients having higher basal ganglia rCBF
levels. Comparing the ROI values of all neuroleptic–naive
schizophrenia patients to medicated ones, a statistical
difference was found in basal ganglia rCBF levels
(p<0.05). Controls and schizophrenics showed a
difference in terms of right versus left brain hemisphere
rCBF values in favor of the left side (p<0.05).

N. AYDIN, E. VARO⁄LU, M. D. AYDIN, H. USLU, A. ÇAYKÖYLÜ

Figure.
left basal ganglia

Mean rCBF values of negative and
positive schizophrenic patients

left occipital
left parietal
left parieto-occipit
Brain Region

left parieto-tempor.
left prefrontal
left temporal
right basal ganglia
right occipital
right parietal
right parieto-occip.

Control

right parieto-temp.

Group II

right prefrontal
—

1.1

—

1.0

—

.9

—

.8

—

—

right temporal
1.2

1.3

1.4

Group I
1.5

rCBF ( ROI / Whole Brain )
Table.

Correlations between psychopathological evaluation parameters and rCBF (Spearman Rank Correlation Analysis) ( n=29).

right
prefrontal

right
frontal

left
frontal

left
parietal

right
parieto
temp.

left
parieto
temp.

right
temp.

left
temp.

left
basal
ganglia

Symptoms

Attention

.457*

-.490*

Hallucinations

.592**

Delusions

-.596**

Bizarre behavior

-.478*

Total SAPS

-.595**

.593**

Emotional
withdrawal

.491*

,510*

Motor retardation

-.500**

.514*

Hallucinatory behavior

.613**

Suspiciousness
Unusual thought content

-.546*
.472*

Excitement

.570*
.536*

.602**

**Correlation is significant at the 0.01 level
* Correlation is significant at the 0.05 level

Discussion
We found that group II revealed bitemporal
hypoperfusion, particularly in the right temporal rCBF;
this finding was consistent with other studies (2, 14).

Although there were studies reporting that hypofrontal
rCBF in patients with negative symptoms (4,5,15), we
could not detect such a finding. Guenther et al.(1986)
found that schizophrenics with positive symptoms
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revealed diffuse hyperactivation but we determined a
local rCBF increase in the temporal region (1).
When we examined each of the psychopathology
scores and rCBF correlations, negative symptoms,
attention, emotional withdrawal, and motor retardation
scores especially correlated positively with left parietal
rCBF, and negatively with temporal rCBF. Additionally,
emotional withdrawal was found to be associated with
increased right prefrontal rCBF. Liddle et al.(1992)
detected a relationship between psychomotor poverty
and decreased left superior parietal association cortex and
decreased dorsolateral prefrontal cortex rCBFs (16).
Kawasaki et al.(1992) found a relationship between
affective flattening severity and left middle prefrontal
cortex rCBF. That patients with frontal lobe lesions show
negative symptoms such as slowing of psychomotor
activity, aspontaneity and lack of initiative, confirms the
presence of an association between frontal rCBF and
negative symptoms (17). Prefrontal and temporoparietal
association cortex is a parallel network that facilitates
arousal, attentional and motivation functions (18) and, in
our study, that negative symptoms have an association
with these three regions may indicate the possible role of
these three regions on the onset of negative symptoms.
When positive symptoms were examined, we found
that delusions correlated positively with right temporal
rCBF and unusual thought content positively with
prefrontal rCBF. Rubin et al. (14) and Sabri et al. (19)
found that thought disorders were related with high rCBF
in the temporal and prefrontal cortex. In our study,
delusions correlated negatively with left parieto-temporal
rCBF and hallucinations correlated positively with right

temporal rCBF(14,19). Recently, it was reported that
patients with temporal lobe lesions or dysfunctions have
auditory hallucinations (20). On the other hand, some
studies reported patients with a recent history of auditory
hallucinations showing an atypical right temporal lobe
dominance (21,22). These findings suggest that the
auditory hallucinations in schizophrenia may be involved
in functional hyperactivity in the temporal cortex.
Although there was a tendency for discrimination of
schizophrenia as negative/positive, in our experience both
symptoms usually present together in one patient. In this
study, we determined that both negative and positive
symptoms were related with frontal, parietal and
temporal rCBF. Because different symptoms were related
to different brain region rCBF levels in our study, we
thought that schizophrenic symptoms might result from
dysfunction of a system including frontal, temporal and
parietal regions, which may be considered an
heteromodal association cortex.
In conclusion, we think that schizophrenic symptoms
might be related to prefrontal and temporo-parietal
association cortices, particularly auditory hallucinations
with temporal rCBF; but to illuminate these thoughts,
more specific brain regions must be examined by using
more sensitive techniques and with large patient groups.
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